GlucoTrack (GCTK) Competitors

Beyond Air (NASDAQ:XAIR) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Does the MarketBeat Community prefer XAIR or GCTK?

Beyond Air received 48 more outperform votes than GlucoTrack when rated by MarketBeat users.

Company	Underperform	Outperform
Beyond Air	Outperform Votes 48 69.57%	Underperform Votes 21 30.43%
GlucoTrack	N/A	N/A

Is XAIR or GCTK more profitable?

GlucoTrack has a net margin of 0.00% compared to Beyond Air's net margin of -1,730.00%. Beyond Air's return on equity of -226.01% beat GlucoTrack's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-1,730.00%	-226.01%	-109.75%
GlucoTrack	N/A	-826.43%	-707.26%

Do analysts rate XAIR or GCTK?

Beyond Air presently has a consensus price target of $1.50, suggesting a potential upside of 747.94%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than GlucoTrack.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
GlucoTrack	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media favor XAIR or GCTK?

In the previous week, GlucoTrack had 1 more articles in the media than Beyond Air. MarketBeat recorded 3 mentions for GlucoTrack and 2 mentions for Beyond Air. GlucoTrack's average media sentiment score of 1.44 beat Beyond Air's score of 0.94 indicating that GlucoTrack is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GlucoTrack	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings & valuation, XAIR or GCTK?

GlucoTrack has lower revenue, but higher earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.02M	5.05	-$60.24M	-$1.06	-0.17
GlucoTrack	N/A	N/A	-$7.10M	-$56.60	0.00

Do insiders and institutionals hold more shares of XAIR or GCTK?

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 10.9% of GlucoTrack shares are held by institutional investors. 19.4% of Beyond Air shares are held by company insiders. Comparatively, 12.9% of GlucoTrack shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Which has more risk and volatility, XAIR or GCTK?

Beyond Air has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, GlucoTrack has a beta of -0.19, meaning that its share price is 119% less volatile than the S&P 500.

Summary

Beyond Air beats GlucoTrack on 12 of the 17 factors compared between the two stocks.